Simplex Trading’s Microbot Medical MBOT Stock Holding History

Simplex Trading’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$136K	Sell	56,500 -130,600	-70%	-$292K	﹤0.01%	4736
2025 Q4	$374K	Sell	187,100 -196,900	-51%	-$466K	﹤0.01%	3597
2025 Q3	$1.17M	Buy	384,000 +144,300	+60%	+$450K	﹤0.01%	2894
2025 Q2	$604K	Buy	239,700 +166,400	+227%	+$398K	﹤0.01%	3302
2025 Q1	$110K	Buy	+73,300	New	+$130K	﹤0.01%	4961
2024 Q1	–	Sell	-800	Closed	-$1K	–	9429
2023 Q4	$1K	Buy	+800	New	+$1.06K	﹤0.01%	8520
2023 Q3	–	Sell	-1,300	Closed	-$3K	–	9344
2023 Q2	$3K	Buy	+1,300	New	+$2.6K	﹤0.01%	8237

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Simplex Trading's MBOT Position: Q1 2026 in Review

Simplex Trading reduced its Microbot Medical (MBOT) stake by 23% in Q1 2026, selling an estimated $36.6K and leaving 54,842 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #4764.

Simplex Trading first reported a position in MBOT in Q1 2023 and has held it in 5 quarters since. The position peaked at $142K in Q4 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

Simplex Trading held 54,842 shares of Microbot Medical worth $132K as of Q1 2026.
Simplex Trading sold 16,385 Microbot Medical shares in Q1 2026, an estimated $36.6K.
Microbot Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4764 holding.
Simplex Trading first reported a position in Microbot Medical in Q1 2023 and has held it in 5 quarters since.
Simplex Trading's Microbot Medical position peaked at $142K in Q4 2025.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.